
Basic Protective Measures Against COVID-19
COVID-19 is a new strain of the common cold that has been p...
COVID-19 is a new strain of the common cold that has been p...
Where is Rivastigmine Tartrate used?
Rivastigmine Tartrate is a prescription used for the treatment of dementia. It is related to Alzheimer’s disease and Parkinson’s disease. This belongs to the class of medications called cholinesterase inhibitors. This comes as a capsule for oral administration. The Food and Drug Administration (FDA) already approved this medication.
How does Rivastigmine Tartrate work?
Rivastigmine Tartrate slows the breakdown of a neurotransmitter in the brain called acetylcholine. Neurotransmitters are stored in nerve cells in the brain and nervous system. These are also involved in transmitting messages between the nerve cells. The acetylcholinesterase is being broken down by another natural chemical as wells as acetylcholine in the brain is repeatedly being released by nerve cells.
One of the features of both Alzheimer’s disease and Parkinson’s disease appears to be a lower than normal level of acetylcholine in the brain. This is a part of the degeneration of brain cells, in particular, those that usually release acetylcholine. This drug increases the level of acetylcholine in the brain. It is by preventing the action of acetylcholinesterase which is the compound that usually breaks it down. This reduces the collapse of acetylcholine that is unconstrained from lasting safe nerve cells in the brain.
This medication may take as long as 12 weeks to begin working. Individual responses to this medication will vary. This drug does not affect the basic progressive process of the disease. The result of this is an increased activity of acetylcholine in the brain. This improves the cognitive processes like learning and memory, thinking, and improves symptoms of dementia.
How is Rivastigmine Tartrate taken?
What are the possible side effects of Rivastigmine Tartrate?
What are the precautions in taking Rivastigmine Tartrate?